EMEA-000827-PIP03-11
Key facts
| Invented name |
Cayston
|
| Active substance |
Aztreonam
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0026/2013
|
| PIP number |
EMEA-000827-PIP03-11
|
| Pharmaceutical form(s) |
Powder and solvent for nebuliser solution
|
| Condition(s) / indication(s) |
Treatment of Gram-negative endobronchial infection in bronchiectasis patients
|
| Route(s) of administration |
Inhalation use
|
| Contact for public enquiries |
Gilead Sciences International Ltd
E-mail: regulatory.pip@gilead.com
Country: United Kingdom Tel. +44 (0)1223 897300 Fax +44 (0)1223 897284 |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|